ArticleOncology letters2025
Gastrointestinal metastasis in prostate cancer and therapeutic implications: A case report.
Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate cancer remains one of the most commonly diagnosed malignancies in men globally, with a notable proportion presenting at the metastatic stage. Whilst metastases predominantly affect lymph nodes, bones, lungs and liver, reports of metastasis to the digestive system are rare, posing unique challenges in prognosis and management. The present study reports a rare case of metastatic prostate adenocarcinoma to the colon, providing information on its clinical characteristics and therapeutic approach. The patient began hormonal intensification therapy resulting in a rapid decline in prostate specific antigen levels and a favorable clinical response over 3 years. Understanding the management of digestive metastases is crucial for optimizing patient outcomes. Diagnostic evaluation should include a colonoscopy, whilst therapeutic decisions are guided by hormonal therapy with or without chemotherapy. Local treatments have limited utility and molecular profiling aids in tailoring treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.